Wei Lanfeng became the vice president and chief operating officer of Porsche China, and Porsche announced that Philipp von Witzendorff will officially become the vice president and chief operating officer of Porsche China from January 1st, 2025. It is understood that in the past two years, Wei Lanfeng has served as President and CEO of Porsche Japan.A total of 211 cases of monkeypox have been reported in France this year. The French Public Health Agency issued a communique on the 11th, saying that 211 cases of monkeypox have been reported in France this year, including 2 new cases in the past two weeks. The communique said that these monkeypox patients are all adults, including 203 males and 8 females. According to reports, after viral gene sequencing, 168 cases were infected with monkeypox virus II, of which 61 cases were further diagnosed as infected monkeypox virus IIb. (Xinhua News Agency)The yield spread of US 10-year Treasury bonds relative to China's has widened to about 250 basis points, the largest in 22 years.
According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) was the same as that of the previous day, with an average price of 76,450 yuan/ton.Supreme Law: If the heir abandons the decedent, he shall lose the right of inheritance. On December 12th, the Supreme People's Court released the typical cases of inheritance disputes (the second batch). In case 4, Gao Moujia and Gao Xiaomou are related to each other, and Gao Xiaomou is an only child. In 1992, Gao Xiaomou (at the age of 20) left home after a dispute with his parents, and he never cared about his parents. Mother didn't take care of her when she was ill, and she didn't go to her funeral when she died. When Gao Moujia was seriously ill, he needed transportation, nursing and care for major surgery, but Gao Xiaomou did not appear. After Gao Moujia died, Gao Xiaomou ignored the burial of his ashes, but as the only legal heir, he received some bank deposit certificates under Gao Moujia's name. According to the Supreme Law, the people's court ruled that his behavior constituted abandonment according to law and sentenced him to lose the right of inheritance, which demonstrated the positive guidance of the law to social values, was conducive to carrying forward the traditional virtues of filial piety and respect for the elderly of the Chinese nation, and improved the mechanism for giving play to the role of family education and family style construction in grassroots governance.Market news: South Korea's ruling party has elected a new party leader, and the new leader said that a presidential election may be held soon.
The retail sector rose and strengthened, and more than 10 stocks such as Yonghui Supermarket rose and strengthened. More than 10 stocks such as Yonghui Supermarket, Maoye Commercial, Zhongbai Group, Nanning Department Store, Youhao Group and Dongbai Group rose and strengthened.Consumer stocks in Hong Kong stocks fluctuated higher, with the same journey rising by more than 6%, Mengniu Dairy rising by more than 4%, and China Resources Beer, Master Kong Holdings and Haidilao rising.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14